TY  - GEN
AU  - van Mulligen,E
AU  - Weel,A E A M
AU  - Kuijper,T M
AU  - Hazes,J M W
AU  - van der Helm-van Mil,A H M
AU  - de Jong,P H P
TI  - The impact of a disease flare during tapering of DMARDs on the lives of rheumatoid arthritis patients
SN  - 1532-866X
PY  - 2021///0427
KW  - Aged
KW  - Antirheumatic Agents
KW  - administration & dosage
KW  - Arthritis, Rheumatoid
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - Drug Tapering
KW  - methods
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Minimal Clinically Important Difference
KW  - Patient Reported Outcome Measures
KW  - Physical Functional Performance
KW  - Quality of Life
KW  - Symptom Flare Up
KW  - Time Factors
KW  - Tumor Necrosis Factor Inhibitors
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.semarthrit.2020.02.011
ER  -